Companies › HCWB
HCW Biologics Inc (HCWB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001828673 · EDGAR filings · Updated 2026-07-16
HCW Biologics Inc (HCWB) has reported institutional ownership of 6.7%, with 15 institutional managers holding positions valued at $160.8K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-16 — POS AM filed
- 2026-07-01 — Current report (8-K) filed
- 2026-06-30 — Current report (8-K) filed
- 2026-06-26 — Current report (8-K) filed
- 2026-06-18 — EFFECT filed
- 2026-06-18 — S-1/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, HCW Biologics Inc has 15 institutional holders and institutional ownership of 6.7%.
Insider activity
Insiders reported 9 transactions (9 buys, 0 sells) across 6 reporting insiders, with a net reported value of $3.05M.
Data flags from SEC filings
Related companies
XTL BIOPHARMACEUTICALS LTD (XTLB) · Genprex Inc (GNPX) · CURANEX PHARMACEUTICALS INC (CURX) · SONOMA PHARMACEUTICALS INC (SNOA) · VivoSim Labs Inc (VIVS) · CHINA SXT PHARMACEUTICALS IN (SXTC)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.